Suppliers / Saurav Chemicals

Saurav Chemicals

India Updated 9 July 2026

Saurav Chemicals is an API manufacturer based in India. It holds 2 active US drug master files across a filed portfolio of 6 molecules. Customs aggregates show $4.7M of exports covering 53 molecules to 22 destinations in 2025.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Atropine SFDA (Saudi Arabia) 1
Celecoxib US FDA 1
Chlorzoxazone US FDA 1
Dexketoprofen SFDA (Saudi Arabia) 1
Pregabalin SFDA (Saudi Arabia) 1
Vildagliptin SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Scale

Year Revenue Exports Destinations
2025 Not reported $4.7M 22
2024 Not reported $22.6M 51
2023 Not reported $39.8M 45
2022 Not reported $24.0M 50

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Saurav Chemicals

Does Saurav Chemicals hold a US DMF or a CEP?
Saurav Chemicals holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Saurav Chemicals make?
6 molecules are on record against Saurav Chemicals, including Atropine, Celecoxib, Chlorzoxazone and Dexketoprofen. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Saurav Chemicals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
Customs aggregates
Export values, molecule and destination counts